Literature DB >> 25211852

Beta blocking eye drops in acute migraine: a novel use of an old drug.

Brandi R French, Niranjan N Singh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25211852      PMCID： PMC6179459     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


× No keyword cloud information.
  14 in total

1.  Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil.

Authors:  Wengui Yu; Steven H Horowitz
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

2.  The possible treatment of migraine with carteolol hydrochloride.

Authors:  M K Shapiro; R Gorn
Journal:  Headache       Date:  1999-02       Impact factor: 5.887

3.  Pharmacokinetic and pharmacodynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon TG).

Authors:  Yoshiyuki Ohno; Tatuji Iga; Yasuhiko Yamada; Miyuki Nagahara; Makoto Araie; Risa Takayanagi
Journal:  Curr Eye Res       Date:  2005-04       Impact factor: 2.424

4.  A randomized open-label study of sodium valproate vs sumatriptan and metoclopramide for prolonged migraine headache.

Authors:  Babak Bakhshayesh; Seyed Mohammad Seyed Saadat; Kourosh Rezania; Hamidreza Hatamian; Mozaffar Hossieninezhad
Journal:  Am J Emerg Med       Date:  2013-02-04       Impact factor: 2.469

5.  Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

Review 6.  First-pass elimination. Basic concepts and clinical consequences.

Authors:  S M Pond; T N Tozer
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

7.  Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study.

Authors:  Dawn C Buse; Aubrey N Manack; Kristina M Fanning; Daniel Serrano; Michael L Reed; Catherine C Turkel; Richard B Lipton
Journal:  Headache       Date:  2012-07-25       Impact factor: 5.887

Review 8.  Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects.

Authors:  T Nieminen; T Lehtimäki; J Mäenpää; A Ropo; H Uusitalo; M Kähönen
Journal:  Scand J Clin Lab Invest       Date:  2007       Impact factor: 1.713

9.  Propranolol in the treatment of acute migraine attacks.

Authors:  M Banerjee; L Findley
Journal:  Cephalalgia       Date:  1991-09       Impact factor: 6.292

10.  Treatment of headache in the elderly.

Authors:  Linda A Hershey; Edward M Bednarczyk
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598
View more
  2 in total

1.  It Should Not Be This Difficult to Engage Pharma in an Effective, Safe, Inexpensive Product for Acute Migraine, the Third Most Prevalent Disease in the World.

Authors:  John C Hagan
Journal:  Mo Med       Date:  2022 Jan-Feb

2.  A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine.

Authors:  Dipika Aggarwal; Andrew J Heim; Brennen Bittel; Deetra Ford; Richard Dubinsky; Gary Gronseth; Vernita Hairston; Patrick Landazuri; Fred Sachen; Laura Herbelin; Richard J Barohn
Journal:  Kans J Med       Date:  2020-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.